RxBNProcrit
epoetin alfa
1 reference · 1 biosimilar-only
Reference Product
Procrit
epoetin alfa
351(a) Reference Product (Approval Date —)
ApplicantAmgen Inc.
BLA103234
RouteIntravenous, Subcutaneous
Presentation
Single-Dose Vial
Procrit
epoetin alfa
351(a) Reference Product (Approval Date —)
ApplicantAmgen Inc.
BLA103234
·RouteIntravenous, Subcutaneous
Presentation
Single-Dose Vial
Interchangeable Biosimilars
No interchangeable biosimilars in this group.
Biosimilars (not interchangeable)
Retacrit
epoetin alfa-epbx
351(k) Biosimilar (Approval Date 15-May-2018)
ApplicantHospira Inc., a Pfizer Company
BLA125545
RouteIntravenous, Subcutaneous
Presentation
Multi-Dose VialSingle-Dose Vial
Retacrit
epoetin alfa-epbx
351(k) Biosimilar (Approval Date 15-May-2018)
ApplicantHospira Inc., a Pfizer Company
BLA125545
·RouteIntravenous, Subcutaneous
Presentation
Multi-Dose VialSingle-Dose Vial